Nucleic Acids Research, 1990, Vol. 18, No. 19 5609-5615
© 1990
MOLECULAR BIOLOGY |
The importance of the 3'-enhancer region in immunoglobulin x gene expression
MRC Laboratory of Molecular Biology Hills Road, Cambridge CB2 2QH, UK 1Institute of Animal Physiology and Genetics Research Babraham, Cambridge CB2 4AT, UK
*To whom correspondence should be addressed
Received August 13, 1990. Accepted September 3, 1990.
The first enhancers to be identified In the immunoglobulin gene loci are located In the J-C Intron. However, deletion of the immunoglobulin x intronenhancer has little effect on the transcription of x transgenes. Here we ask whether the second x enhancer which we recently identified at the 3'-end of the locus plays a role in x gene expression. We show that its omission leads to 20–40 fold lower expression of x transgenes and to poor allelic exclusion. Transfection experiments show that activity of the 3'-enhancer, like that of the x-intron enhancer, can be induced in a pre-B cell line by incubation with bacterial lipopolysaccharide. Whereas induction of the x-intron enhancer is due to induction of NF-xB actMty, deletion mapping of the 3'-enhancer localises its activity to a 50 nucleotide region that lacks an NF-xB. site; indeed the 3'-enhancer allows x expression in a cell line which lacks NF-xB. Thus, both the 3'- and intron-enhancers can be induced at the same stage of differentiation but by distinct pathways. Furthermore, unlike the intron enhancer, the 3'-enhancer plays a critical role in the transcription of rearranged immunoglobulin x genes.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. C. McDevit, L. Perkins, M. L. Atchison, and B. S. Nikolajczyk The Ig{kappa}3' Enhancer Is Activated by Gradients of Chromatin Accessibility and Protein Association J. Immunol., March 1, 2005; 174(5): 2834 - 2842. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. L. Morvan, E. Pinaud, C. Decourt, A. Cuvillier, and M. Cogne The immunoglobulin heavy-chain locus hs3b and hs4 3' enhancers are dispensable for VDJ assembly and somatic hypermutation Blood, August 15, 2003; 102(4): 1421 - 1427. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Liu, M. Linden, and B. Van Ness Induced {kappa} Receptor Editing Shows No Allelic Preference in a Mouse Pre-B Cell Line J. Immunol., December 15, 2000; 165(12): 7058 - 7063. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. E. Wittekindt, K. Hortnagel, C. Geltinger, and A. Polack Activation of c-myc promoter P1 by immunoglobulin {kappa} gene enhancers in Burkitt lymphoma: functional characterization of the intron enhancer motifs {kappa}B, E box 1 and E box 2, and of the 3' enhancer motif PU Nucleic Acids Res., February 1, 2000; 28(3): 800 - 808. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-i. Hashimoto, H. Nishizumi, R. Hayashi, A. Tsuboi, F. Nagawa, T. Takemori, and H. Sakano Prf, a novel Ets family protein that binds to the PU.1 binding motif, is specifically expressed in restricted stages of B cell development Int. Immunol., September 1, 1999; 11(9): 1423 - 1429. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Liu, A. Prabhu, and B. Van Ness Developmental Regulation of the kappa Locus Involves Both Positive and Negative Sequence Elements in the 3' Enhancer That Affect Synergy with the Intron Enhancer J. Biol. Chem., February 5, 1999; 274(6): 3285 - 3293. [Abstract] [Full Text] [PDF]
|
|